Undeterred by the turbulence in U.S. and global markets, Sergey Young and his Longevity Vision Fund persist in their quest for the ultimate goal: providing individuals with the opportunity to enjoy up to 130 years of meaningful and healthy living. The entrepreneur is gearing up to launch a groundbreaking enterprise focused on developing "immortality supplements," expected to debut in 2024.
Sergey Young's Nature-Defying Approach
Standing out as a unique entrepreneur, Sergey Young is driven not by profit, but by a goal that challenges conventional norms and, some might argue, even challenges nature. For over two decades, the Longevity Vision Fund and numerous similar ventures have pursued the ambitious objective of "making the future happen today" through innovative longevity supplements.
These ventures have embarked on "expeditions" into uncharted territory, where a lifespan of over 100 years is the norm, not the exception.
Sergey Young is no stranger to this promised land, and he is armed with three degrees—in business administration from Warwick Business School, in chemistry, and in economics. These diverse qualifications empower him to take a visionary approach, seeking solutions at the crossroads of biology, medicine, and technology, with his ventures often delving into the realm of science fiction.
His book, "The Science and Technology of Growing Young," has swiftly become a guide for scientists and the general public alike, catering to those who yearn for immortality. The Hungarian edition of "The Growing Young" was released in October 2023, with Young's second book anticipated soon.
Young's latest non-profit endeavor, the Healthspan Xprize Foundation, is a leading initiative uniting scientists from 50 countries. Set to launch in 2024, the Healthspan Xprize project aims to create a "magical immortality pill"—a genetic supplement erasing "age markers" from human DNA, effectively halting biological clocks.
As part of this audacious goal, Sergey Young is initiating a research project named "Targeting Aging with Metformin" (aka “TAME”) in 2024. This trial involves taming the aging process using supplements traditionally used to treat pancreatic diabetes. The six-year clinical research, encompassing 3000 volunteers aged 65 to 80, is all set to go.
Young's Immortality Empire
Sergey Young's "empire of longevity" extends beyond the Longevity Vision Fund, encompassing a constellation of companies dedicated to various aspects of achieving longevity, if not immortality. These include:
- Life Biosciences (reprogramming and regenerating complicated cells)
- Fountain Life (developing AI tools for advanced heart attack forecasts)
- Tessera Therapeutics (genetic therapy and repair of damaged DNA sequences)
- Freenome (AI-based blood testing for early cancer diagnostics)
- Insilico Medicine (AI-based supplement development)
- LyGenesis (organ regeneration using a patient’s own cells)
- Peak State Ventures (exploring the future of work, technologies for property and healthcare)
- Bold Capital Partners (investments in exponential technologies)
Young, despite overseeing this extensive network and serving as a member of the Healthspan Xprize’sInnovation Board and the American Federation for Aging Research, actively engages with representatives from nearly 200 biotechnological companies annually. This exchange of information focuses on the latest anti-aging technologies, highlighting Young's commitment as a responsible researcher who relies on rigorously tested and scientifically proven solutions in his pursuit of longevity and immortality.
Unsurprisingly, as a proponent of longevity philosophy, Sergey Young feels compelled to showcase how he personally combats aging. His lifestyle includes yoga, meditation, a healthy diet, and intermittent fasting.
Those acquainted with the entrepreneur note that Sergey Young can’t live without gadgets like the Apple Watch step counter, Oura Ring sleep quality monitor, Aktiia blood pressure meter, and more. Additionally, to stay positive and balanced, Young prioritizes loving relationships with his wife and four children, complemented by regular travel.